178 related articles for article (PubMed ID: 30384042)
1. Synthesis and biological evaluation of novel H6 analogues as drug resistance reversal agents.
Wang X; Ren QW; Liu XX; Yang YT; Wang BH; Zhai R; Qi JG; Tian JW; Wang HB; Bi Y
Eur J Med Chem; 2019 Jan; 161():364-377. PubMed ID: 30384042
[TBL] [Abstract][Full Text] [Related]
2. H6, a novel hederagenin derivative, reverses multidrug resistance in vitro and in vivo.
Yang Y; Guan D; Lei L; Lu J; Liu JQ; Yang G; Yan C; Zhai R; Tian J; Bi Y; Fu F; Wang H
Toxicol Appl Pharmacol; 2018 Feb; 341():98-105. PubMed ID: 29408042
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of hederagenin derivatives with improved aqueous solubility and tumor resistance reversal activity.
Wang B; Liu S; Huang W; Ma M; Chen X; Zeng W; Liang K; Wang H; Bi Y; Li X
Eur J Med Chem; 2021 Feb; 211():113107. PubMed ID: 33360797
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of novel α-hederagenin derivatives with anticancer activity.
Liu XX; Yang YT; Wang X; Wang KY; Liu JQ; Lei L; Luo XM; Zhai R; Fu FH; Wang HB; Bi Y
Eur J Med Chem; 2017 Dec; 141():427-439. PubMed ID: 29040953
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and tumor drug resistance reversal activity of novel hederagenin derivatives modified by nitrogen-containing heterocycles.
Huang W; Wang Y; Xu S; Qiao H; Cheng H; Wang L; Liu S; Tian Q; Wang R; Wang H; Bi Y
Eur J Med Chem; 2022 Mar; 232():114207. PubMed ID: 35219948
[TBL] [Abstract][Full Text] [Related]
6. Discovery and synthesis of 3- and 21-substituted fusidic acid derivatives as reversal agents of P-glycoprotein-mediated multidrug resistance.
Guo M; Ren Q; Wang B; Ji W; Ni J; Feng Y; Bi Y; Tian J; Wang H
Eur J Med Chem; 2019 Nov; 182():111668. PubMed ID: 31505451
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and discovery of ocotillol-type amide derivatives as orally available modulators of P-glycoprotein-mediated multidrug resistance.
Ren Q; Yang G; Guo M; Guo J; Li Y; Lu J; Yang Q; Tang H; Li Y; Fang X; Sun Y; Qi JG; Tian J; Wang H
Eur J Med Chem; 2019 Jan; 161():118-130. PubMed ID: 30347326
[TBL] [Abstract][Full Text] [Related]
8. Hederagenin as a triterpene template for the development of new antitumor compounds.
Rodríguez-Hernández D; Demuner AJ; Barbosa LC; Csuk R; Heller L
Eur J Med Chem; 2015 Nov; 105():57-62. PubMed ID: 26476750
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of hydantoin bridged analogues of combretastatin A-4 as potential anticancer agents.
Zhang M; Liang YR; Li H; Liu MM; Wang Y
Bioorg Med Chem; 2017 Dec; 25(24):6623-6634. PubMed ID: 29126741
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of CDDO-amino acid-nitric oxide donor trihybrids as potential antitumor agents against both drug-sensitive and drug-resistant colon cancer.
Ai Y; Kang F; Huang Z; Xue X; Lai Y; Peng S; Tian J; Zhang Y
J Med Chem; 2015 Mar; 58(5):2452-64. PubMed ID: 25675144
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576.
Mistry P; Stewart AJ; Dangerfield W; Okiji S; Liddle C; Bootle D; Plumb JA; Templeton D; Charlton P
Cancer Res; 2001 Jan; 61(2):749-58. PubMed ID: 11212278
[TBL] [Abstract][Full Text] [Related]
12. Boc-lysinated-betulonic acid: a potent, anti-prostate cancer agent.
Saxena BB; Zhu L; Hao M; Kisilis E; Katdare M; Oktem O; Bomshteyn A; Rathnam P
Bioorg Med Chem; 2006 Sep; 14(18):6349-58. PubMed ID: 16777417
[TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis, and Evaluation of in Vitro and in Vivo Anticancer Activity of 4-Substituted Coumarins: A Novel Class of Potent Tubulin Polymerization Inhibitors.
Cao D; Liu Y; Yan W; Wang C; Bai P; Wang T; Tang M; Wang X; Yang Z; Ma B; Ma L; Lei L; Wang F; Xu B; Zhou Y; Yang T; Chen L
J Med Chem; 2016 Jun; 59(12):5721-39. PubMed ID: 27213819
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of betulonic acid derivatives as antitumor agents.
Yang SJ; Liu MC; Zhao Q; Hu DY; Xue W; Yang S
Eur J Med Chem; 2015; 96():58-65. PubMed ID: 25874331
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, Characterization and Anti-hepatoma Activity of New Hederagenin Derivatives.
Liu X; Sun L; Liu QH; Chen BQ; Liu YM
Mini Rev Med Chem; 2020; 20(3):252-257. PubMed ID: 32134368
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and cytotoxicity evaluation of oleanolic acid derivatives.
Hao J; Liu J; Wen X; Sun H
Bioorg Med Chem Lett; 2013 Apr; 23(7):2074-7. PubMed ID: 23434227
[TBL] [Abstract][Full Text] [Related]
17. Reversal of paclitaxel resistance in human ovarian cancer cells with redox-responsive micelles consisting of α-tocopheryl succinate-based polyphosphoester copolymers.
Chen FQ; Zhang JM; Fang XF; Yu H; Liu YL; Li H; Wang YT; Chen MW
Acta Pharmacol Sin; 2017 Jun; 38(6):859-873. PubMed ID: 28260803
[TBL] [Abstract][Full Text] [Related]
18. Discovery of novel β-carboline/acylhydrazone hybrids as potent antitumor agents and overcome drug resistance.
Li Y; Yan W; Yang J; Yang Z; Hu M; Bai P; Tang M; Chen L
Eur J Med Chem; 2018 May; 152():516-526. PubMed ID: 29754076
[TBL] [Abstract][Full Text] [Related]
19. A novel curcumin derivative which inhibits P-glycoprotein, arrests cell cycle and induces apoptosis in multidrug resistance cells.
Lopes-Rodrigues V; Oliveira A; Correia-da-Silva M; Pinto M; Lima RT; Sousa E; Vasconcelos MH
Bioorg Med Chem; 2017 Jan; 25(2):581-596. PubMed ID: 27908756
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological evaluation of ocotillol derivatives fused with 2-aminothiazole via A-ring as modulators of P-glycoprotein-mediated multidrug resistance.
Wang Y; Zhang D; Ma G; Su Z; Liu M; Wang R; Meng Q; Bi Y; Wang H
Eur J Med Chem; 2022 Dec; 243():114784. PubMed ID: 36167009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]